Missing or deficient enzymes can cause rare genetic disorders by disrupting normal metabolism. Discover how enzyme replacement therapy works, its benefits, limitations, and role in treating rare metabolic disorders.
Articles exploring how orphan drug designation works, why rare disease medicines can be expensive, how access decisions are made, and what patients can realistically expect from new therapies.
We also report on treatment approvals, clinical trial results, safety updates, and changes in availability across different countries. Alongside news and analysis, we signpost reliable sources of information, patient organisations, and specialist centres where people may find further guidance or support.
The aim is to provide clear, evidence-based information about treatments without exaggerating benefits or minimising uncertainty.
Understanding Enzyme Replacement Therapy
Missing or deficient enzymes can cause rare genetic disorders by disrupting normal metabolism. Discover how enzyme replacement therapy works, its benefits, limitations, and role in treating rare metabolic disorders.
Amyotrophic Lateral Sclerosis: Motor Neuron Degeneration, Cellular Mechanisms, and Clinical Progression
A clear, in-depth overview of Amyotrophic Lateral Sclerosis, exploring motor neuron degeneration, genetic and molecular mechanisms, clinical symptoms, disease progression, and current research directions.
Understanding Small Molecule Treatments
Discover what small molecule treatments are, how they work inside the body, and why they play a key role in treating many rare diseases.
Understanding Multidisciplinary Clinics for Rare Diseases
Multidisciplinary clinics for rare diseases unite specialists from different fields to collaborate on diagnosis and treatment, helping patients receive faster answers, coordinated care, and access to advanced therapies."
Why Rare Disease Treatments Take Longer To Reach Patients
For millions living with rare diseases, effective treatments remain out of reach. Learn why drug development takes longer for rare conditions and how innovation is starting to close the gap.
Orphan Drugs: From Neglect to Precision Medicine
Although orphan drug legislation and genomic science have transformed the therapeutic landscape for rare diseases, the path from scientific discovery to patient access remains complex and uncertain.